ImmunityBio (IBRX) FCF Margin (2014 - 2026)
ImmunityBio's (IBRX) quarterly FCF Margin came in at 172.94% in Q1 2026, up 34716.0% year-on-year from N/an in Q1 2025, and up 6.92% on a QoQ basis from 185.8% in Q4 2025.
ImmunityBio (IBRX) FCF Margin (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of FCF Margin data on file, last reported at 172.94% in Q1 2026.
- On a quarterly basis, FCF Margin rose 34716.0% year-over-year to 172.94% in Q1 2026; TTM through Mar 2026 was 210.53%, a 97455.0% increase from a year earlier, with the FY2025 full-year figure at 270.33%, up 239053.0% from the prior year.
- FCF Margin for Q1 2026 stood at 172.94%, up from 185.8% in the prior quarter.
- Over the last five years, FCF Margin for IBRX reached as high as 172.94% in Q1 2026 and fell as low as 534492.86% in Q1 2022.
- Historically, FCF Margin has averaged 107467.1% across 5 years, with a median of 28706.39% in 2023.
- Across the five-year window, FCF Margin plunged 48792020 bps in 2022 and soared 50578647 bps in 2023, its largest moves.
- Year by year, FCF Margin stood at 150216.44% in 2022, then jumped by 51 bps to 73816.55% in 2023, then soared by 99 bps to 1078.85% in 2024, then jumped by 83 bps to 185.8% in 2025, then advanced by 7 bps to 172.94% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 172.94% in Q1 2026, 185.8% in Q4 2025, and 209.66% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | -172.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -172.94% |
| Dec 31, 2025 | -185.80% |
| Sep 30, 2025 | -209.66% |
| Jun 30, 2025 | -310.30% |
| Mar 31, 2025 | -520.10% |
| Dec 31, 2024 | -1,078.85% |
| Sep 30, 2024 | -1,646.66% |
| Jun 30, 2024 | -9,749.86% |
| Mar 31, 2024 | -270,607.50% |
| Dec 31, 2023 | -73,816.55% |
| Sep 30, 2023 | -99,208.54% |
| Jun 30, 2023 | -189,497.56% |
| Mar 31, 2023 | -28,706.39% |
| Dec 31, 2022 | -150,216.44% |
| Sep 30, 2022 | -81,809.32% |
| Jun 30, 2022 | -384,711.43% |
| Mar 31, 2022 | -534,492.86% |
| Dec 31, 2021 | -18,146.67% |
| Sep 30, 2021 | -111,153.03% |
| Jun 30, 2021 | -20,509.44% |